Free Trial

Chemours (CC) Competitors

Chemours logo
$16.33 -0.43 (-2.56%)
As of 10:05 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

CC vs. ASIX, DD, DOW, EMN, HUN, NTR, OLN, TKR, TROX, and WLK

Should you be buying Chemours stock or one of its competitors? The main competitors of Chemours include AdvanSix (ASIX), DuPont de Nemours (DD), DOW (DOW), Eastman Chemical (EMN), Huntsman (HUN), Nutrien (NTR), Olin (OLN), Timken (TKR), Tronox (TROX), and Westlake (WLK).

Chemours vs. Its Competitors

Chemours (NYSE:CC) and AdvanSix (NYSE:ASIX) are both basic materials companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, media sentiment, risk, dividends, profitability, analyst recommendations, institutional ownership and valuation.

Chemours currently has a consensus target price of $17.38, indicating a potential upside of 5.33%. AdvanSix has a consensus target price of $33.50, indicating a potential upside of 55.38%. Given AdvanSix's stronger consensus rating and higher probable upside, analysts clearly believe AdvanSix is more favorable than Chemours.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Chemours
0 Sell rating(s)
4 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.56
AdvanSix
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Chemours pays an annual dividend of $0.35 per share and has a dividend yield of 2.1%. AdvanSix pays an annual dividend of $0.64 per share and has a dividend yield of 3.0%. Chemours pays out -12.5% of its earnings in the form of a dividend. AdvanSix pays out 22.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. AdvanSix has raised its dividend for 2 consecutive years. AdvanSix is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

76.3% of Chemours shares are owned by institutional investors. Comparatively, 86.4% of AdvanSix shares are owned by institutional investors. 0.5% of Chemours shares are owned by company insiders. Comparatively, 5.6% of AdvanSix shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, Chemours had 5 more articles in the media than AdvanSix. MarketBeat recorded 9 mentions for Chemours and 4 mentions for AdvanSix. AdvanSix's average media sentiment score of 1.64 beat Chemours' score of 0.93 indicating that AdvanSix is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Chemours
5 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
AdvanSix
4 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

AdvanSix has a net margin of 5.10% compared to Chemours' net margin of -7.19%. Chemours' return on equity of 35.14% beat AdvanSix's return on equity.

Company Net Margins Return on Equity Return on Assets
Chemours-7.19% 35.14% 2.45%
AdvanSix 5.10%10.02%4.97%

Chemours has a beta of 1.61, meaning that its share price is 61% more volatile than the S&P 500. Comparatively, AdvanSix has a beta of 1.64, meaning that its share price is 64% more volatile than the S&P 500.

Chemours has higher revenue and earnings than AdvanSix. Chemours is trading at a lower price-to-earnings ratio than AdvanSix, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Chemours$5.78B0.43$86M-$2.80-5.89
AdvanSix$1.52B0.38$44.15M$2.847.59

Summary

AdvanSix beats Chemours on 12 of the 19 factors compared between the two stocks.

Get Chemours News Delivered to You Automatically

Sign up to receive the latest news and ratings for CC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CC vs. The Competition

MetricChemoursCHEM IndustryMaterials SectorNYSE Exchange
Market Cap$2.47B$11.55B$3.60B$21.47B
Dividend Yield2.15%3.11%5.06%3.51%
P/E Ratio-5.9027.43158.6929.94
Price / Sales0.435.7716,042.4950.54
Price / Cash4.417.4824.2424.51
Price / Book4.071.676.774.60
Net Income$86M$508.39M$149.32M$999.91M
7 Day Performance5.43%0.73%1.80%1.28%
1 Month Performance33.13%6.96%9.93%5.31%
1 Year Performance-3.88%2.53%44.72%16.45%

Chemours Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CC
Chemours
3.4502 of 5 stars
$16.50
-1.6%
$17.38
+5.3%
-1.6%$2.47B$5.78B-5.906,000
ASIX
AdvanSix
3.7737 of 5 stars
$21.39
+1.5%
$33.50
+56.6%
-19.7%$574.19M$1.52B7.531,450Positive News
DD
DuPont de Nemours
4.4642 of 5 stars
$77.02
-0.8%
$88.25
+14.6%
-2.4%$32.25B$12.61B-163.8824,000Positive News
Insider Trade
DOW
DOW
4.3415 of 5 stars
$24.63
+0.2%
$30.74
+24.8%
-50.6%$17.46B$42.96B-17.5936,000Analyst Forecast
EMN
Eastman Chemical
4.8792 of 5 stars
$70.26
+3.1%
$87.00
+23.8%
-31.3%$8.07B$9.38B9.8714,000News Coverage
Positive News
HUN
Huntsman
4.2215 of 5 stars
$11.17
+2.6%
$12.06
+7.9%
-47.7%$1.94B$6.04B-5.736,300Analyst Forecast
Short Interest ↓
NTR
Nutrien
4.0894 of 5 stars
$57.73
-1.8%
$62.65
+8.5%
+25.1%$28.06B$25.97B20.6925,500Positive News
Analyst Forecast
Analyst Revision
OLN
Olin
3.3161 of 5 stars
$23.67
+3.5%
$25.57
+8.0%
-33.9%$2.71B$6.66B-197.237,780Positive News
Short Interest ↑
TKR
Timken
4.2486 of 5 stars
$77.26
-1.2%
$79.80
+3.3%
+0.3%$5.38B$4.51B17.5619,000Analyst Revision
TROX
Tronox
4.1096 of 5 stars
$4.32
+4.0%
$5.01
+16.1%
-57.4%$684.04M$2.95B-2.736,500Trending News
WLK
Westlake
3.7231 of 5 stars
$87.95
+1.8%
$92.29
+4.9%
-34.0%$11.28B$12.14B-165.9315,540Positive News

Related Companies and Tools


This page (NYSE:CC) was last updated on 9/12/2025 by MarketBeat.com Staff
From Our Partners